Literature DB >> 2197047

Strain differences in mouse cellular responses to Mycobacterium lepraemurium and BCG subcutaneous infections. I. Analysis of cell surface phenotype in local granulomas.

F Roch1, M A Bach.   

Abstract

C57BL/6, BALB/c and CBA mice were subcutaneously infected with either Mycobacterium lepraemurium (MLM) or BCG, and studied for bacillary growth, granuloma size of infected footpads and draining lymph nodes (DLN), and DLN cell surface phenotype. Whereas, BCG-infected mice controlled the infection and developed early and large granulomas, MLM-infected mice exhibited major strain variations in their resistance to the infection, as well as in the granuloma size and kinetics. C57BL/6 mice, highly resistant, displayed early and regressive granulomas; BALB/c mice showed lower resistance and early granulomas that grew continuously; CBA mice, highly susceptible, developed late, soft, phagocyte-rich granulomas. Important strain differences in lymph node lymphocyte subset distribution could be observed prior to any infection: C57BL/6 mice displayed higher B cell percentages than both of the other strains and BALB/c mice showed the highest CD4/CD8 ratios, followed by CBA and C57BL/6 mice. BCG and MLM infections both induced similar changes of these parameters in all three strains: that is a decrease of the B cell percentage and a decrease of the CD4/CD8 ratio, and the strain differences observed in uninfected mice persisted. On the other hand, DLN cells stimulated by the infecting bacillus and interleukin 2 also displayed an increase of the CD8 T cell percentage as compared with normal lymph node cells, but this phenomenon was much less pronounced in BALB/c mice, whether infected by MLM or BCG, and in MLM-infected CBA mice, than in BCG- or MLM-infected C57BL/6 (B6) mice. Thus the ability of C57BL/6 mice to generate an early and persistent CD8 T cell response to mycobacteria may contribute to their resistance to MLM.

Entities:  

Mesh:

Year:  1990        PMID: 2197047      PMCID: PMC1535205     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  32 in total

1.  A monoclonal antibody discriminating between subsets of T and B cells.

Authors:  J Bruce; F W Symington; T J McKearn; J Sprent
Journal:  J Immunol       Date:  1981-12       Impact factor: 5.422

2.  Studies on T cell subsets and functions in leprosy.

Authors:  M A Bach; L Chatenoud; D Wallach; F Phan Dinh Tuy; F Cottenot
Journal:  Clin Exp Immunol       Date:  1981-06       Impact factor: 4.330

3.  A lack of correlation between antigen-specific cellular reactions and resistance to Mycobacterium lepraemurium infection in mice.

Authors:  J Curtis; H O Adu; J L Turk
Journal:  Immunology       Date:  1981-06       Impact factor: 7.397

4.  Classification of leprosy according to immunity. A five-group system.

Authors:  D S Ridley; W H Jopling
Journal:  Int J Lepr Other Mycobact Dis       Date:  1966 Jul-Sep

5.  Lymphocytes bearing antigen-specific gamma delta T-cell receptors accumulate in human infectious disease lesions.

Authors:  R L Modlin; C Pirmez; F M Hofman; V Torigian; K Uyemura; T H Rea; B R Bloom; M B Brenner
Journal:  Nature       Date:  1989-06-15       Impact factor: 49.962

6.  Development of delayed hypersensitivity responses in Mycobacterium lepraemurium infections in resistant and susceptible strains of mice.

Authors:  J Alexander; J Curtis
Journal:  Immunology       Date:  1979-03       Impact factor: 7.397

7.  Effect of cyclophosphamide treatment on the course of Mycobacterium lepraemurium infection and development of delayed-type hypersensitivity reactions in C57B1 and BALB/c mice.

Authors:  J Alexander
Journal:  Clin Exp Immunol       Date:  1978-10       Impact factor: 4.330

8.  A repopulation assay for B and T lymphocyte stem cells employing radiation chimaeras.

Authors:  S V Hunt; M H Fowler
Journal:  Cell Tissue Kinet       Date:  1981-07

9.  Inhibition of murine T cell-mediated cytolysis and T cell proliferation by a rat monoclonal antibody immunoprecipitating two lymphoid cell surface polypeptides of 94 000 and 180 000 molecular weight.

Authors:  M Pierres; C Goridis; P Golstein
Journal:  Eur J Immunol       Date:  1982-01       Impact factor: 5.532

10.  Genetic control of natural resistance to Mycobacterium bovis (BCG) in mice.

Authors:  P Gros; E Skamene; A Forget
Journal:  J Immunol       Date:  1981-12       Impact factor: 5.422

View more
  6 in total

1.  An orthologous non-MHC locus in rats and mice is linked to CD4+ and CD8+ T-cell proportion.

Authors:  D Franckaert; R Collin; J Dooley; R H Wallis; P Poussier; A Liston; E E Hillhouse; S Lesage
Journal:  Genes Immun       Date:  2017-05-25       Impact factor: 2.676

2.  Immune-mediated anti-neoplastic effect of intratumoral RSV envelope glycoprotein expression is related to apoptotic death of tumor cells but not to the size of syncytia.

Authors:  Dennis Hoffmann; Thomas Grunwald; Wibke Bayer; Oliver Wildner
Journal:  World J Gastroenterol       Date:  2008-03-28       Impact factor: 5.742

3.  T-cell lung granulomas induced by sepharose-coupled Mycobacterium tuberculosis protein antigens: immunosuppressive phenomena reversed with cyclophosphamide and indomethacin.

Authors:  R Hernández-Pando; H Orozco; R Mancilla
Journal:  Immunology       Date:  1995-12       Impact factor: 7.397

4.  In situ tumor vaccination with adenovirus vectors encoding measles virus fusogenic membrane proteins and cytokines.

Authors:  Dennis Hoffmann; Wibke Bayer; Oliver Wildner
Journal:  World J Gastroenterol       Date:  2007-06-14       Impact factor: 5.742

5.  Detection of Salmonella-specific L3T4+ and Lyt-2+ T cells which can proliferate in vitro and mediate delayed-type hypersensitivity reactivity.

Authors:  M Pope; I Kotlarski
Journal:  Immunology       Date:  1994-02       Impact factor: 7.397

6.  Enhanced monocyte recruitment and delayed alternative macrophage polarization accompanies impaired repair following myocardial infarction in C57BL/6 compared to BALB/c mice.

Authors:  I S Toor; D Rückerl; I Mair; A Thomson; A G Rossi; D E Newby; J E Allen; G A Gray
Journal:  Clin Exp Immunol       Date:  2019-06-17       Impact factor: 4.330

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.